1. Home
  2. MRVI vs BFS Comparison

MRVI vs BFS Comparison

Compare MRVI & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$5.21

Market Cap

770.0M

Sector

Health Care

ML Signal

HOLD

BFS

Saul Centers Inc.

HOLD

Current Price

$35.82

Market Cap

809.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
BFS
Founded
2014
1993
Country
United States
United States
Employees
N/A
98
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
770.0M
809.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MRVI
BFS
Price
$5.21
$35.82
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$4.13
$44.00
AVG Volume (30 Days)
2.6M
60.2K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
6.92%
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
N/A
Revenue This Year
$12.54
$0.30
Revenue Next Year
$7.87
$5.67
P/E Ratio
N/A
$30.48
Revenue Growth
N/A
N/A
52 Week Low
$1.99
$29.16
52 Week High
$5.32
$38.42

Technical Indicators

Market Signals
Indicator
MRVI
BFS
Relative Strength Index (RSI) 67.64 53.03
Support Level $3.27 $32.56
Resistance Level N/A $38.42
Average True Range (ATR) 0.25 0.89
MACD -0.01 -0.09
Stochastic Oscillator 81.45 44.03

Price Performance

Historical Comparison
MRVI
BFS

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.

Share on Social Networks: